Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare, aggressive neuroendocrine carcinoma that arises from the cervix and is characterized by the presence of malignant cells with abundant cytoplasm, large nuclei, and prominent nucleoli.
Biomarker and diagnostic research for cervical large cell neuroendocrine carcinoma has been reported in the published literature.
1 clinical trial registered. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
173 publications have been identified in PubMed for cervical large cell neuroendocrine carcinoma. Research spans Case Report / Case Series (26%), Review / Meta-Analysis (17%), and Basic Science / Preclinical (16%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 45 | 26% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 11:13 AM UTC
Research summaries |
30 |
17% |
Laboratory research | 28 | 16% |
Disease patterns and progression | 27 | 16% |
Clinical study results | 26 | 15% |
Testing and diagnosis research | 15 | 9% |
New treatment approaches | 2 | 1% |
Wang SY (2026). [PMID: 41609724](https://pubmed.ncbi.nlm.nih.gov/41609724/). *JAMA otolaryngology-- head & neck surgery*. [Review / Meta-Analysis]
Moi R (2026). [PMID: 42035253](https://pubmed.ncbi.nlm.nih.gov/42035253/). *Am J Case Rep*. [Review / Meta-Analysis]
Al Tabaa O (2026). [PMID: 41640080](https://pubmed.ncbi.nlm.nih.gov/41640080/). *The American journal of case reports*. [Case Report / Case Series]
Kang Y (2026). [PMID: 42118669](https://pubmed.ncbi.nlm.nih.gov/42118669/). *Cancer Control*. [Epidemiology / Natural History]
Kasajima A (2026). [PMID: 41483302](https://pubmed.ncbi.nlm.nih.gov/41483302/). *Virchows Archiv : an international journal of pathology*. [Review / Meta-Analysis]
Hirose T (2026). [PMID: 41924640](https://pubmed.ncbi.nlm.nih.gov/41924640/). *Surgical case reports*. [Case Report / Case Series]
Bou Zerdan M (2026). [PMID: 41785530](https://pubmed.ncbi.nlm.nih.gov/41785530/). *Gynecologic oncology*. [Clinical Trial Publication]
Sohel HI (2026). [PMID: 41828610](https://pubmed.ncbi.nlm.nih.gov/41828610/). *International journal of molecular sciences*. [Basic Science / Preclinical]
Zhou Y (2026). [PMID: 41535264](https://pubmed.ncbi.nlm.nih.gov/41535264/). *Nature communications*. [Basic Science / Preclinical]
Wakana K (2026). [PMID: 42152606](https://pubmed.ncbi.nlm.nih.gov/42152606/). *J Obstet Gynaecol Res*. [Case Report / Case Series]
AI-curated news mentioning cervical large cell neuroendocrine carcinoma
Updated Mar 6, 2026
A recent study published in PubMed examines the clinicopathologic characteristics and survival outcomes of patients with high-grade neuroendocrine cervical cancer. The findings contribute to the understanding of this rare cancer type, although specific survival metrics were not detailed in the excerpt.